EN
HI
Unjha Formulations Share price
UNJHAFOR
30.641.45 (4.97%)
Last updated on 4 Sep, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 6 Sep, 2026, Unjha Formulations stock price is ₹30.64. During the trading session, the stock has moved between an intraday low of ₹30.50 and an intraday high of ₹30.64. Over the last 52 weeks, Unjha Formulations has traded between ₹17.52 and ₹30.64.
The stock has recorded a trading volume of 15,131 shares, with a market capitalization of ₹4480500. Its Average Traded Price (ATP) is ₹30.61, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 311 @ ₹30.64.
Unjha Formulations has an upper circuit limit of ₹32.17 and a lower circuit limit of ₹29.11. The total value traded stands at ₹4.63 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Unjha Formulations also offers a dividend yield of 0%.
Unjha Formulations share price chart
Unjha Formulations Share Key Metrics
Volume
15131.00
Market Cap
13.73 CR
LTQ@LTP
311@30.64
ATP
30.61
Var Margin
100 %
Circuit Range
29.11-32.17
Delivery %
100 %
Value
4.63 L
ASM/GSM
No
Market Lot
1
Unjha Formulations Resistance and Support
Pivot 29.13
Resistance
First Resistance
29.26
Second Resistance
29.32
Third Resistance
29.45
Support
First Support
29.07
Second Support
28.94
Third Support
28.88
Unjha Formulations Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
36.92%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
63.08%
Others
0%
Total Promoters
MAR '23
36.92%
JUN '23
36.92%
SEP '23
36.92%
DEC '23
36.92%
Unjha Formulations Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-18 | Audited Results |
| 2026-02-04 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-03-17 | Others |
| 2025-02-04 | Quarterly Results |
| 2024-11-08 | Quarterly Results |
| 2024-08-01 | Quarterly Results |
Unjha Formulations News
Unjha Formulations Ltd - 531762 - Cash Flow Statement For The Year Ended 31.03.2026
Unjha Formulations reported strong financial performance for FY26 with net cash inflow from operations reaching Rs.124.38 crore, a significant turnaround from the Rs.4.49 crore outflow in FY25. The company's cash and cash equivalents also rose to Rs.164.48 crore.
Aug 14 2026 18:39:18
Unjha Formulations Ltd - 531762 - Cash Flow Statement For The Year Ended 31.03.2026
Unjha Formulations reported strong financial performance for FY26 with net cash inflow from operations reaching Rs.124.38 crore, a significant turnaround from the Rs.4.49 crore outflow in FY25. The company's cash and cash equivalents also rose to Rs.164.48 crore.
Aug 14 2026 18:38:25
Unjha Formulations Management
| Name | Position |
|---|---|
| Jashodaben S Patel | Chairperson |
| Krutiben M Patel | Managing Director & Compliance Officer |
Unjha Formulations Similar Stocks
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
132.45
0.00 (0.00%)
Colinz Laboratories Ltd.
72.56
1.06 (1.48%)
Broach Lifecare Hospital Ltd.
15.50
0.00 (0.00%)
Ortin Global Ltd.
15.01
-0.18 (1.18%)
Kobo Biotech Ltd.
5.10
-0.09 (1.73%)
Starsource Multitrade Ltd.
80.95
0.58 (0.72%)
Hindustan Bio Sciences Ltd.
7.45
0.10 (1.36%)
Unjha Formulations FAQs
The Buying Price of Unjha Formulations share is 30.64 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Unjha Formulations stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Unjha Formulations, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Unjha Formulations shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Unjha Formulations shares is 0. Useful to assess the stock's value relative to its book value.
To assess Unjha Formulations’s valuation compare Sector P/E, P/B which are 41.43 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Unjha Formulations is 13.73 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Unjha Formulations share price is 30.64 & 17.52. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Unjha Formulations belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in UNJHAFOR
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC